ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Two Sarcoma Drugs Pose Classic Question: How Much PFS Does it Take to Get a Nod?

March 30, 2012

In Brief: Gerald Dodd, Walter Lawrence Head ACS; Reauthorization Bills Expected Early ‘91

November 16, 1990

In Brief: Gilbert Fletcher, Father of Modern Radiotherapy, Dead At 80 In Houston; Built First Cobalt-60 Unit

January 24, 1992

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

IOM To Form Committee To Investigate Duke Genomics Research

October 1, 2010

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002